SHARE:  
DONATE

Thank you!

Your generosity during our successful Commit to a Cure campaign is funding our vital research and patient resource initiatives. With your help, we are more determined than ever to defeat stomach cancer.


If you haven't yet made a donation, please consider giving today.

New in 2025

A New Resource for Patients and Families

The foundation is excited to launch an original video series, “Your New Normal: Conversations about Living with Gastric Cancer."


When a cancer diagnosis is received, it impacts every part of life—not just physically, but emotionally and personally as well. Today, a lot of medical and scientific information about cancer is available, but the personal side of the journey can feel overlooked. Too often, patients and families face these challenges without enough support.  That’s the need behind creation of this new series.  


We’re fortunate to have Hans Rueffert, a gastric cancer survivor and the host of our popular Gesundheit Kitchen series, as our moderator. With his warm, relatable style and firsthand experience, Hans will help normalize the ups and downs of the cancer journey. In conversations with patients, caregivers and a variety of experts, the videos will share actionable tips to make daily life just a little easier.


“We are stronger together,” stresses Rueffert. “In each video, we’ll take a deep dive into real-life concerns. We’ll tackle tough topics and focus on what truly matters to you. I encourage you to share the videos with friends and family to spark new conversations.”

Learn More

Episode 1: Your Fears and Emotions

In this first episode, Hans sits down with two mental health professionals to discuss the intense thoughts and feelings that naturally accompany a gastric cancer diagnosis. Together, they explore strategies for handling and sharing these emotions on your journey. Remember, you don’t have to face it alone!

Watch Now

We invite your feedback!

Please share your thoughts on this first video, and let us know what future topics you’d like us to explore. Your feedback and ideas will help us make "Your New Normal" even better.

This project is supported by special grants from Astellas and Amgen.

Take a Look at the Clinical Trial Finder

The free no-obligation Clinical Trial Finder provides streamlined access to information about cutting-edge clinical studies that could make additional treatment options available to you.

Find a Match

Research Roundup

The FDA approved BeiGene’s Tevimbra plus chemotherapy to treat metastatic gastric cancer. The approval was based on trial data showing a clinically meaningful improvement in overall survival.


In preclinical studies, combining the experimental drug pelcitoclax with chemotherapy was effective against HER2-positive gastric cancer. The drug is designed to overcome resistance to HER2-targeted drugs by binding to two tumor targets and inducing the death of cancer cells.


In a recent study, adding a novel HER2 antibody to a treatment of trastuzumab and chemotherapy prolonged progression-free survival in advanced gastric cancer.

Quick Links to Resources

JOIN THE REGISTRY
FIND CLINICAL TRIALS
OUR ONLINE COMMUNITY
Special Thanks to Our
National Sustaining Sponsors
Facebook  Twitter  Linkedin  Youtube  
Spread the word. Share the Gastric Cancer Foundation Newsletter.
X Share This Email
LinkedIn Share This Email